Literature DB >> 31769007

Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Ioanna Andreadou1, Rainer Schulz2, Lina Badimon3,4,5, Adriana Adameová6,7, Petra Kleinbongard8, Sandrine Lecour9, Panagiota-Efstathia Nikolaou1, Ines Falcão-Pires10, Gemma Vilahur3,4, Nicholas Woudberg9, Gerd Heusch8, Péter Ferdinandy11,12.   

Abstract

Hyperlipidaemia is a well-established risk factor for cardiovascular diseases and therefore, many animal model have been developed to mimic the human abnormal elevation of blood lipid levels. In parallel, extensive research for the alleviation of ischaemia/reperfusion injury has revealed that hyperlipidaemia is a major co-morbidity that attenuates the cardioprotective effect of conditioning strategies (preconditioning, postconditioning and remote conditioning) and that of pharmacological interventions by interfering with cardioprotective signalling pathways. In the present review article, we summarize the existing data on animal models of hypercholesterolaemia (total, low density and HDL abnormalities) and hypertriglyceridaemia used in ischaemia/reperfusion injury and protection from it. We also provide recommendations on preclinical animal models to be used for translations of the cardioprotective strategies into clinical practice. LINKED ARTICLES: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.23/issuetoc.
© 2019 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2020        PMID: 31769007      PMCID: PMC7680007          DOI: 10.1111/bph.14931

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  149 in total

1.  Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy.

Authors:  Petra Keul; Amin Polzin; Klaus Kaiser; Markus Gräler; Lisa Dannenberg; Günter Daum; Gerd Heusch; Bodo Levkau
Journal:  FASEB J       Date:  2018-08-21       Impact factor: 5.191

2.  Adverse interaction between HDL and the mass of myocardial infarction.

Authors:  Alexandre A S Soares; Luiz Sergio F Carvalho; Isabella Bonilha; Vitor W Virginio; Wilson Nadruz Junior; Otavio Rizzi Coelho-Filho; Jose C Quinaglia E Silva; Orlando Petrucci Junior; Andrei C Sposito
Journal:  Atherosclerosis       Date:  2018-12-06       Impact factor: 5.162

Review 3.  Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Authors:  Ioanna Andreadou; Rainer Schulz; Lina Badimon; Adriana Adameová; Petra Kleinbongard; Sandrine Lecour; Panagiota-Efstathia Nikolaou; Ines Falcão-Pires; Gemma Vilahur; Nicholas Woudberg; Gerd Heusch; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

4.  Hereditary postprandial hypertriglyceridemic rabbit exhibits insulin resistance and central obesity: a novel model of metabolic syndrome.

Authors:  Takashi Kawai; Tsunekata Ito; Kazuo Ohwada; Yasuko Mera; Mutsuyoshi Matsushita; Hitonobu Tomoike
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-21       Impact factor: 8.311

5.  Effect of Saffron on Metabolic Profile and Retina in Apolipoprotein E-Knockout Mice Fed a High-Fat Diet.

Authors:  Evangelos K Doumouchtsis; Aspasia Tzani; Ilias P Doulamis; Panagiotis Konstantopoulos; Korou Laskarina-Maria; Georgios Agrogiannis; Emmanouil Agapitos; Marilita M Moschos; Alkiviadis Kostakis; Despina N Perrea
Journal:  J Diet Suppl       Date:  2017-09-22

6.  Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse.

Authors:  H V de Silva; J Más-Oliva; J M Taylor; R W Mahley
Journal:  J Lipid Res       Date:  1994-07       Impact factor: 5.922

7.  Ischemia-reperfusion arrhythmias and lipids: effect of human high- and low-density lipoproteins on reperfusion arrhythmias.

Authors:  S Mochizuki; M Okumura; F Tanaka; T Sato; A Kagami; N Tada; M Nagano
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

8.  Aortic atherosclerosis in pigs with heterozygous von Willebrand disease. Comparison with homozygous von Willebrand and normal pigs.

Authors:  L Badimon; P Steele; J J Badimon; E J Bowie; V Fuster
Journal:  Arteriosclerosis       Date:  1985 Jul-Aug

9.  European Society of Cardiology: Cardiovascular Disease Statistics 2017.

Authors:  Adam Timmis; Nick Townsend; Chris Gale; Rick Grobbee; Nikos Maniadakis; Marcus Flather; Elizabeth Wilkins; Lucy Wright; Rimke Vos; Jeroen Bax; Maxim Blum; Fausto Pinto; Panos Vardas
Journal:  Eur Heart J       Date:  2018-02-14       Impact factor: 29.983

10.  Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet.

Authors:  Yanling Ma; Wenyi Wang; Jie Zhang; Youli Lu; Wenyu Wu; Hong Yan; Yiping Wang
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

View more
  18 in total

1.  Risk factors, co-morbidities, and co-medications in cardioprotection: Importance for translation.

Authors:  Rainer Schulz; Ioanna Andreadou; Derek J Hausenloy; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-12       Impact factor: 8.739

Review 2.  Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Authors:  Ioanna Andreadou; Rainer Schulz; Lina Badimon; Adriana Adameová; Petra Kleinbongard; Sandrine Lecour; Panagiota-Efstathia Nikolaou; Ines Falcão-Pires; Gemma Vilahur; Nicholas Woudberg; Gerd Heusch; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

Review 3.  Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms.

Authors:  Tetsuji Miura; Tatsuya Sato; Toshiyuki Yano; Akira Takaguri; Takayuki Miki; Noritsugu Tohse; Keitaro Nishizawa
Journal:  Cardiovasc Drugs Ther       Date:  2022-02-12       Impact factor: 3.727

Review 4.  Citrus Extract as a Perspective for the Control of Dyslipidemia: A Systematic Review With Meta-Analysis From Animal Models to Human Studies.

Authors:  Betina M R Carvalho; Laranda C Nascimento; Jessica C Nascimento; Vitória S Dos S Gonçalves; Patricia K Ziegelmann; Débora S Tavares; Adriana G Guimarães
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

Review 5.  Dare to Compare. Development of Atherosclerotic Lesions in Human, Mouse, and Zebrafish.

Authors:  Viviana L Vedder; Zouhair Aherrahrou; Jeanette Erdmann
Journal:  Front Cardiovasc Med       Date:  2020-06-30

Review 6.  PCSK9 in Myocardial Infarction and Cardioprotection: Importance of Lipid Metabolism and Inflammation.

Authors:  Ioanna Andreadou; Maria Tsoumani; Gemma Vilahur; Ignatios Ikonomidis; Lina Badimon; Zoltán V Varga; Péter Ferdinandy; Rainer Schulz
Journal:  Front Physiol       Date:  2020-11-12       Impact factor: 4.566

Review 7.  Mouse models of atherosclerosis and their suitability for the study of myocardial infarction.

Authors:  Pelin Golforoush; Derek M Yellon; Sean M Davidson
Journal:  Basic Res Cardiol       Date:  2020-11-30       Impact factor: 17.165

8.  Comparing the effectiveness of Chinese patent medicines containing red yeast rice on hyperlipidaemia: A network meta-analysis of randomized controlled trials.

Authors:  Guiqin Xu; Mingxin Lin; Xueli Dai; Jingqing Hu
Journal:  Endocrinol Diabetes Metab       Date:  2021-11-11

9.  Effects on cardiac function, remodeling and inflammation following myocardial ischemia-reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice.

Authors:  Niek J Pluijmert; Cindy I Bart; Wilhelmina H Bax; Paul H A Quax; Douwe E Atsma
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

10.  PACAP-38 in Acute ST-Segment Elevation Myocardial Infarction in Humans and Pigs: A Translational Study.

Authors:  Dora Szabo; Zsolt Sarszegi; Beata Polgar; Eva Saghy; Adam Nemeth; Dora Reglodi; Andras Makkos; Aniko Gorbe; Zsuzsanna Helyes; Peter Ferdinandy; Robert Herczeg; Attila Gyenesei; Attila Cziraki; Andrea Tamas
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.